These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bis(benzofuran-thiazolidinone)s and bis(benzofuran-thiazinanone)s as inhibiting agents for chikungunya virus. Hwu JR; Gupta NK; Tsay SC; Huang WC; Albulescu IC; Kovacikova K; van Hemert MJ Antiviral Res; 2017 Oct; 146():96-101. PubMed ID: 28830714 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d]pyrimidin-7(6 H)-ones. Gómez-SanJuan A; Gamo AM; Delang L; Pérez-Sánchez A; Amrun SN; Abdelnabi R; Jacobs S; Priego EM; Camarasa MJ; Jochmans D; Leyssen P; Ng LFP; Querat G; Neyts J; Pérez-Pérez MJ ACS Infect Dis; 2018 Apr; 4(4):605-619. PubMed ID: 29406692 [TBL] [Abstract][Full Text] [Related]
6. Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus. Bassetto M; De Burghgraeve T; Delang L; Massarotti A; Coluccia A; Zonta N; Gatti V; Colombano G; Sorba G; Silvestri R; Tron GC; Neyts J; Leyssen P; Brancale A Antiviral Res; 2013 Apr; 98(1):12-8. PubMed ID: 23380636 [TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of silymarin against chikungunya virus. Lani R; Hassandarvish P; Chiam CW; Moghaddam E; Chu JJ; Rausalu K; Merits A; Higgs S; Vanlandingham D; Abu Bakar S; Zandi K Sci Rep; 2015 Jun; 5():11421. PubMed ID: 26078201 [TBL] [Abstract][Full Text] [Related]
8. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection. Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship study of arbidol derivatives as inhibitors of chikungunya virus replication. Di Mola A; Peduto A; La Gatta A; Delang L; Pastorino B; Neyts J; Leyssen P; de Rosa M; Filosa R Bioorg Med Chem; 2014 Nov; 22(21):6014-25. PubMed ID: 25282648 [TBL] [Abstract][Full Text] [Related]
11. Antiviral activity of nobiletin against chikungunya virus in vitro. Lin SC; Chen MC; Li S; Lin CC; Wang TT Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093 [TBL] [Abstract][Full Text] [Related]
12. The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines. Franco EJ; Rodriquez JL; Pomeroy JJ; Hanrahan KC; Brown AN Antivir Chem Chemother; 2018; 26():2040206618807580. PubMed ID: 30354193 [TBL] [Abstract][Full Text] [Related]
13. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents. Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048 [TBL] [Abstract][Full Text] [Related]
14. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo. Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398 [TBL] [Abstract][Full Text] [Related]
15. Antiviral Hammerhead Ribozymes Are Effective for Developing Transgenic Suppression of Chikungunya Virus in Aedes aegypti Mosquitoes. Mishra P; Furey C; Balaraman V; Fraser MJ Viruses; 2016 Jun; 8(6):. PubMed ID: 27294950 [TBL] [Abstract][Full Text] [Related]
16. LC-MS²-Based dereplication of Euphorbia extracts with anti-Chikungunya virus activity. Nothias-Scaglia LF; Dumontet V; Neyts J; Roussi F; Costa J; Leyssen P; Litaudon M; Paolini J Fitoterapia; 2015 Sep; 105():202-9. PubMed ID: 26151856 [TBL] [Abstract][Full Text] [Related]
17. Discovery of Novel Peptidomimetics as Irreversible CHIKV NsP2 Protease Inhibitors Using Quantum Mechanical-Based Ligand Descriptors. El-labbad EM; Ismail MA; Abou Ei Ella DA; Ahmed M; Wang F; Barakat KH; Abouzid KA Chem Biol Drug Des; 2015 Dec; 86(6):1518-27. PubMed ID: 26212366 [TBL] [Abstract][Full Text] [Related]
19. Identification of 6'-β-fluoro-homoaristeromycin as a potent inhibitor of chikungunya virus replication. Shin YS; Jarhad DB; Jang MH; Kovacikova K; Kim G; Yoon JS; Kim HR; Hyun YE; Tipnis AS; Chang TS; van Hemert MJ; Jeong LS Eur J Med Chem; 2020 Feb; 187():111956. PubMed ID: 31841728 [TBL] [Abstract][Full Text] [Related]
20. Development of a Real-Time Cell Analysing (RTCA) method as a fast and accurate screen for the selection of chikungunya virus replication inhibitors. Marlina S; Shu MH; AbuBakar S; Zandi K Parasit Vectors; 2015 Nov; 8():579. PubMed ID: 26553263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]